Emergent BioSolutions (EBS) Divestments (2023 - 2024)
Emergent BioSolutions (EBS) posted Divestments of $110.2 million for FY2024, down 59.2% from $270.2 million in FY2023.
Powered by 
Analysis
Emergent BioSolutions (EBS) Divestments (2023 - 2024) Analysis & Trends
- Business Quant data shows EBS's Divestments at $270.2 million in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.56 Bn | 1,127.15 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 625.11 Bn | 543.63 Bn | 17.26 Bn | - |
| 3 | AbbVie | 510.90 Bn | 484.01 Bn | 12.70 Bn | - |
| 4 | Merck | 366.23 Bn | 320.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.31 Bn | 261.30 Bn | 11.24 Bn | 62.00 Mn |
| 6 | Astrazeneca | 261.14 Bn | 234.82 Bn | 12.86 Bn | - |
| 7 | Amgen | 234.96 Bn | 190.36 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | - |
| 10 | Emergent BioSolutions | 316.57 Mn | -434.33 Mn | 137.20 Mn | - |
API Access
Emergent BioSolutions Divestments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=divestments&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "divestments", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=divestments&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();